Skip to content
Search

Latest Stories

Diabetes advice ‘should be culturally responsive’

By Amit Roy

A LEADING diabetes doctor has advised British Asians on how they can reduce their risks from Covid-19 by taking up NHS programmes aimed at dealing with the disease.

The comments from Prof Partha Kar, national speciality adviser for diabetes for NHS England, follow the publication last week of disturbing statistics which showed that more than a quarter of NHS patients who died in hospitals in England af­ter contracting coronavirus had suffered with diabetes.


Of the 22,332 patients who died in England’s hospitals be­tween March 31, when pre-ex­isting conditions began to be recorded, and last Tuesday (12), some 5,873 – 26 per cent – had either type 1 or type 2 diabetes.

An inquiry by Public Health England (PHE), under Prof Kevin Fenton, national director for health and wellbeing, into BAME deaths is expected to re­port by the end of May.

Prof Kar said: “Data has shown that 26 per cent of the deaths is due to diabetes – a huge number. The next ques­tion is can we now drill into it to find out if there are any obvious areas we need to focus on? Those are the things we need to know for policy reasons.”

In the UK, “the data is not specifically Indian – it is based on ethnicity,” he went on.

“With the southeast Asian population – Indian, Pakistani, Bangladeshi, Sri Lankan – you will very likely see there is a spike so there are more deaths among brown people com­pared to those who are white.”

He expressed regret that Brit­ish Asians appeared to be falling behind as regards their diabe­tes outcomes: “Type 2 diabetes is not ‘one of those things’. It’s a big thing.”

He explained the difference between the two types.

“Type 1 diabetes is some­thing you can’t control. It hap­pens because of an immune problem – nobody knows the reason for it. You lose your abil­ity to produce insulin. At what­ever age it happens, you are dependent on insulin for the rest of your life. It has nothing to do with your lifestyle.”

Type 2 diabetes, on the other hand, which is common among Asians, “is mostly down to life­style. It’s about what you eat, your exercise level. We use cars more, we have TV channels, you don’t have to get up from your sofa. Type 2 diabetes is a bigger risk (to Asians).”

Prof Kar said: “We need the BAME population, es­pecially Indians, Pakistanis, Bangladeshis and Sri Lankans, to join the NHS programmes (on curbing Type 2 dia­betes), whether it be in their care or re­search. We need more Asians in it be­cause that’s where the high risk is.”

He explained: “What Covid-19 has shown starkly is the deaths that you see spread over two or three years we are now seeing it in a far shorter period, which is why it is so noticeable.”

Prof Kar wants NHS cam­paigns to be targeted better. “In the UK, the southeast Asian population needs to also ap­preciate that they need to en­gage with services better. They need to do type 2 diabetes pre­vention programmes.”

But he added that the NHS had a responsibility, too, to en­sure its message on diabetes was getting through to the Asian community.

“Services here need to be re­sponsive to different cultures. You can say to Indian families you should not eat pizzas, but what a lot of them would want is to have better advice about roti, chapati and rice.

“The message has to be tai­lored to the population.”

Prof Kar was born in the UK, where his parents, Deba Prasad Kar and Manju Kar, were both doctors. “My grandfather said he wanted to have his son back. So my father left everything and went back [to India]. I was five, six years old. My father was posted in Darjeeling, then went to Calcutta (now Kolkata).”

He attended Don Bosco, a well-known school in Kolkata, and did his MBBS locally at NRS Medical School & College. “I came back here (to the UK) when I was 25.

“My mother was an anaes­thetist and my father still prac­tises in north Kolkata. At the moment they are both here – they are stuck here. It was their 50th wedding anniversary so we flew them over here to cele­brate. They don’t know when they can go back.”

Prof Kar spoke of some of the cultural issues in Kolkata, which also apply to the UK, where sweet shops in Asian ar­eas of the country do a roaring trade, and not just at weekends.

“If you go to somebody’s house, any function we go to, mishti (sweet) is a big thing. But if you multiply your ceremonies and all your weddings, once-in-a-while mishti becomes a lot. Have it once in a while and en­joy it rather than have it every other night.”

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less